MODULATION OF ANTICARDIOLIPIN ANTIBODIES ANTICOAGULANT ACTIVITY BY A MONOCLONAL-ANTIBODY ANTI-BETA-2-GLYCOPROTEIN-I

被引：0
|
作者：
FERRO, D
VALESINI, G
PINI, C
TINGHINO, R
FALCO, M
VIOLI, F
机构：
[1] UNIV ROME,IST CLIN MED 1,I-00100 ROME,ITALY
[2] IST SUPER SANITA,I-00161 ROME,ITALY
来源：
THROMBOSIS AND HAEMOSTASIS | 1993年 / 69卷 / 06期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：1222 / 1222
页数：1
相关论文
共 50 条
  • [1] ANTICOAGULANT ACTIVITY OF ANTICARDIOLIPIN ANTIBODIES IS BLOCKED BY A MONOCLONAL-ANTIBODY ANTI-BETA2-GLYCOPROTEIN-I (BETA2-GPI)
    FERRO, D
    VALESINI, G
    TINCANI, A
    BALESTRIERI, G
    VEZZA, E
    VIOLI, F
    THROMBOSIS RESEARCH, 1993, 70 : S68 - S68
  • [2] ANTICOAGULANT ACTIVITY OF AN ANTI-BETA-2-GLYCOPROTEIN-I ANTIBODY IS DEPENDENT ON THE PRESENCE OF BETA-2-GLYCOPROTEIN-I
    MATSUDA, J
    GOHCHI, K
    TSUKAMOTO, M
    SAITOH, N
    ASAMI, K
    HASHIMOTO, M
    AMERICAN JOURNAL OF HEMATOLOGY, 1993, 44 (03) : 187 - 191
  • [3] Anti-beta-2-glycoprotein-I IgG antibodies and anticardiolipin IgG antibodies do not predict thrombosis in patients with a persistent lupus anticoagulant
    Koder, S.
    Vormittag, R.
    Zoghlami, C.
    Panzer, S.
    Quehenberger, P.
    Pabinger, I
    JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2009, 7 : 1025 - 1025
  • [4] ANTI-BETA-2-GLYCOPROTEIN-I ANTIBODIES IN SNEDDON SYNDROME
    FRANCES, C
    PIETTE, JC
    VIARD, JP
    TOURBAH, A
    DERMATOLOGY, 1993, 186 (04) : 273 - 273
  • [5] ANTICOAGULANT ACTIVITY OF BETA-2-GLYCOPROTEIN-I IS POTENTIATED BY A DISTINCT SUBGROUP OF ANTICARDIOLIPIN ANTIBODIES
    GALLI, M
    COMFURIUS, P
    BARBUI, T
    ZWAAL, RFA
    BEVERS, EM
    THROMBOSIS AND HAEMOSTASIS, 1992, 68 (03) : 297 - 300
  • [6] ANTICOAGULANT ACTIVITY OF A DISTINCT SUBTYPE OF ANTICARDIOLIPIN ANTIBODIES IS MEDIATED BY BETA-2-GLYCOPROTEIN-I
    GALLI, M
    BARBUI, T
    BEVERS, EM
    THROMBOSIS RESEARCH, 1993, 70 : S68 - S68
  • [7] Anti-beta(2)-glycoprotein I antibodies, anticardiolipin antibodies and lupus anticoagulant in haemodialysis patients.
    GarciaMartin, F
    Piqueras, JA
    Pinedo, B
    deArriba, G
    Teruel, JL
    Sanchez, M
    Jarillo, MD
    JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 1996, 7 (09): : A2633 - A2633
  • [8] Anticardiolipin and anti-beta-2-glycoprotein I antibodies
    Marai, I
    Tincani, A
    Balestrieri, G
    Shoenfeld, Y
    AUTOIMMUNITY, 2005, 38 (01) : 33 - 38
  • [9] Inhibitory effect of beta 2-glycoprotein I on the anticoagulant activity of activated protein C, and its modulation by anti-beta 2-glycoprotein I monoclonal antibodies
    Urano, H
    Takeya, H
    Mori, T
    Gabazza, EC
    Matsuura, E
    Koike, T
    Suzuki, K
    THROMBOSIS AND HAEMOSTASIS, 1997, : P2199 - P2199
  • [10] Are anti-beta-2-glycoprotein-I (aBgp-I) and anticardiolipin (aCL) antibodies markers of auto-immune liver disease?
    Levy, S
    Viard, JP
    Valla, DC
    Degott, C
    Benhamou, JP
    Erlinger, S
    HEPATOLOGY, 1997, 26 (04) : 1681 - 1681
12345